Word

EARLYSTRAND

Status

Pending

Status Code

688

Status Date

Tuesday, September 24, 2024

Serial Number

98285962

Mark Type

4

Filing Date

Monday, November 27, 2023

Published for Opposition

Tuesday, July 30, 2024

Trademark Owner History

Linus Biotechnology Inc. - Owner At Publication

Classifications

9 Laboratory diagnostic kits comprised of a test tube for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer

5 Medical diagnostic kits comprising medical diagnostic reagents to be used in exposomic testing; medical diagnostic kits comprising medical diagnostic reagents for diagnosing autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic reagents and assays for testing hair samples

44 Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic purposes in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for medical purposes

10 Apparatus for exposomic testing for medical purposes; apparatus for analysis of hair samples for medical diagnostic purposes for detecting autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing for detecting autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical devices for testing hair samples for diagnostic purposes for detecting autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic kits comprised of blood collecting, urine collecting, and hair sample collecting tubes for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer

42 Medical and scientific research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer diagnosis; medical research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer treatment and diagnosis; laboratory research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for scientific research purposes

Trademark Events

Jan 17, 2024

New Application Office Supplied Data Entered

Jun 26, 2024

Approved For Pub - Principal Register

Jun 26, 2024

Assigned To Examiner

Jul 10, 2024

Notification Of Notice Of Publication E-Mailed

Jul 30, 2024

Published For Opposition

Jul 30, 2024

Official Gazette Publication Confirmation E-Mailed

Sep 24, 2024

Noa E-Mailed - Sou Required From Applicant

Nov 30, 2023

New Application Entered